- Published at
- by insidermonkey.com
mixed
mixed
12 Penny Stocks with Insider Buying in 2025
Insider trading can be a reliable signal for gauging the degree of confidence that management has in the future of their company.
News for OncoCyte Corporation (OCX)
- Published at
- by insidermonkey.com
positivepositiveOncoCyte Corporation (OCX): Among Cheapest Stocks Insiders Are Buying Recently
We recently published a list of 10 Cheapest Stocks Insiders Are Buying Recently.- Published at
- by insidermonkey.com
mixedmixed10 Cheapest Stocks Insiders Are Buying Recently
Why should we be interested in affordable stocks? Some investors like to look for cheaper stocks in order to diversify their portfolios, because these penny stocks often operate in different industries...- Published at
- by investing.com
positivepositiveOncoCyte stock hits 52-week low at $1.92 amid market challenges By Investing.com
OncoCyte stock hits 52-week low at $1.92 amid market challenges- Published at
- by manilatimes.net
mixedmixed- Published at
- by gurufocus.com
positivepositiveOncocyte Expands Market Opportunity for VitaGraft™ Kidney
Medicare coverage expanded following study showing that monitoring with Oncocyte's assay significantly reduces time to rejection diagnosis in patients with newl- Published at
- by manilatimes.net
positivepositive- Published at
- by investing.com
positivepositiveOncoCyte stock hits 52-week low at $1.98 amid market challenges By Investing.com
OncoCyte stock hits 52-week low at $1.98 amid market challenges- Published at
- by gurufocus.com
neutralneutralOncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
IRVINE, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp. ( OCX), a diagnostics technology company, today announced the publication of favorable data r- Published at
- by gurufocus.com
positivepositiveOncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms
Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population Study shows that monitoring with Oncocyte's ass- Published at
- by manilatimes.net
positivepositive- Published at
- by insidermonkey.com
positivepositiveOncoCyte Corporation (NASDAQ:OCX) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Kayla, and I will be your conference operator today.- Published at
- by seekingalpha.com
positivepositiveOncoCyte Corporation (OCX) Q3 2024 Earnings Call Transcript
OncoCyte Corporation (NASDAQ:OCX) Q3 2024 Results Conference Call November 12, 2024 5:00 PM ETCompany ParticipantsJulie Silber - PCG AdvisoryJosh Riggs -...- Published at
- by marketscreener.com
mixedmixed- Published at
- by benzinga.com
mixedmixedWhy NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket - NextPlat (NASDAQ:NXPL)
Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year- Published at
- by globenewswire.com
mixedmixedBreast Cancer Core Needle Biopsy Market Detailed Analysis Report 2024-2031
Companies covered in this report are Intact Medical Corporation, Ethicon Surgical Technologies, Galling SRL, Leica Biosystems Nussle GmbH, Hologic, Inc,...- Published at
- by marketscreener.com
mixedmixedImmunoPrecise Antibodies : 2023 Notice of Meeting & Information Circular -October 18, 2023 at 03:00 pm EDT
IMMUNOPRECISE ANTIBODIES LTD. Unit 3204 - 4464 Markham Street Victoria, BC V8Z 7X8 NOTICE OF ANNUAL GENERAL MEETING OF...- Published at
- by marketscreener.com
positivepositiveLimitless Earth Plc - Final Results for the year to 31 January 2023
28 July 2023 LIMITLESS EARTH PLC Final Results for the year to 31 January 2023 The Company announces its final results for the year to 31 January 2023. The Annual Report and Accounts for the year...- Published at
- by globenewswire.com
mixedmixed22nd Century Announces Executive Leadership Changes
Expands Board with New Highly Accomplished Independent Director Strengthens Balance Sheet and Implements $15 Million Cost Reduction Initiative ...- Published at
- by etfdailynews.com
positivepositiveHead-To-Head Comparison: FluoroPharma Medical (OTCMKTS:FPMI) and OncoCyte (NASDAQ:OCX)
Read Head-To-Head Comparison: FluoroPharma Medical (OTCMKTS:FPMI) and OncoCyte (NASDAQ:OCX) at ETF Daily News